Overview

Reata Pharmaceuticals, Inc. is a private company aiming to build an enduring, fully integrated pharmaceutical company delivering novel medicines for deadly and difficult-to-treat diseases. Founded with an understanding of the significant technical risk in developing medicines, the business model was built around small cross functional teams, rapid evaluation of projects for biological activity and clinical viability, quick decision making, and intense analysis of scientific data to determine the direction of individual programs.  In addition to internal discovery, we have in-licensed a number of novel potential products from premier academic institutions.  We continue this operating model today and are committed to both developing and in-licensing novel technologies to keep our pipeline strong. 

We intend to play an active role in the commercialization of all our products, and we have entered into partnerships structured to enable Reata to establish a commercial presence initially in the U.S. as well as in key international markets at the appropriate time.  For a better understanding of Reata's progress to date, please view our press releases.